What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Gene
Kjell Öberg mostly deals with Internal medicine, Neuroendocrine tumors, Endocrinology, Pathology and Gastroenterology.
Kjell Öberg combines topics linked to Surgery with his work on Internal medicine.
His Neuroendocrine tumors study incorporates themes from Cancer, Clinical trial, Chromogranin A, Everolimus and Disease.
His Pathology research is multidisciplinary, incorporating elements of Multiple endocrine neoplasia, Oncology and MEDLINE.
His work deals with themes such as Nausea, Unknown primary, Adverse effect and Asymptomatic, which intersect with Gastroenterology.
His biological study deals with issues like Urinary system, which deal with fields such as Alpha interferon.
His most cited work include:
- Everolimus for Advanced Pancreatic Neuroendocrine Tumors (1972 citations)
- Gastroenteropancreatic neuroendocrine tumours. (1225 citations)
- Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors (1042 citations)
What are the main themes of his work throughout his whole career to date?
Kjell Öberg mainly focuses on Internal medicine, Neuroendocrine tumors, Pathology, Endocrinology and Gastroenterology.
His study in Oncology extends to Internal medicine with its themes.
His work in Neuroendocrine tumors covers topics such as Cancer research which are related to areas like Alpha interferon.
His work in Pathology addresses issues such as Endocrine system, which are connected to fields such as Multiple endocrine neoplasia.
Kjell Öberg does research in Endocrinology, focusing on Hormone specifically.
His Gastroenterology research is multidisciplinary, relying on both Progressive disease, Surgery and Chemotherapy.
He most often published in these fields:
- Internal medicine (56.18%)
- Neuroendocrine tumors (37.81%)
- Pathology (32.33%)
What were the highlights of his more recent work (between 2012-2021)?
- Internal medicine (56.18%)
- Neuroendocrine tumors (37.81%)
- Gastroenterology (17.84%)
In recent papers he was focusing on the following fields of study:
His main research concerns Internal medicine, Neuroendocrine tumors, Gastroenterology, Oncology and Endocrinology.
His work on Carcinoid syndrome, Disease, Octreotide and 177Lu-DOTATATE as part of general Internal medicine research is frequently linked to In patient, thereby connecting diverse disciplines of science.
His Neuroendocrine tumors research is included under the broader classification of Pathology.
In Pathology, he works on issues like Small intestine, which are connected to Well differentiated.
As a member of one scientific family, Kjell Öberg mostly works in the field of Gastroenterology, focusing on Lung and, on occasion, Liquid biopsy.
Kjell Öberg works mostly in the field of Oncology, limiting it down to topics relating to Biomarker and, in certain cases, Meta-analysis, as a part of the same area of interest.
Between 2012 and 2021, his most popular works were:
- Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors (1042 citations)
- ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site (468 citations)
- ENETS Consensus Guidelines Update for Neuroendocrine Neoplasms of the Jejunum and Ileum (201 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Gene
Internal medicine, Neuroendocrine tumors, Pathology, Endocrinology and Oncology are his primary areas of study.
Internal medicine is often connected to Gastroenterology in his work.
His Neuroendocrine tumors study combines topics in areas such as Carcinogenesis, Somatostatin, Everolimus, Disease and Tumor progression.
He has included themes like Appendiceal neoplasms and Small intestine in his Pathology study.
His Endocrinology research is multidisciplinary, incorporating perspectives in Jejunal Neoplasm and MEDLINE.
The concepts of his Oncology study are interwoven with issues in Genetic counseling, Translational research and Chemotherapy, Temozolomide.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
